Conditions: BK Viremia
Keywords: BK viremia kidney transplantation BK viremia in kidney transplant recipients
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 43
Healthy volunteers: no

Brief summary:
Our hypothesis is that 30 days of oral levofloxacin (FDA approved antibiotic) in patients with persistent viremia (BK virus found in blood) will impair progress to BK virus induced kidney damage by significantly decreasing or eliminating BK virus in the blood.

Detailed description:

Arms:
arm 1: Levofloxacin 500 mg every day (dose adjusted for renal function) for 30 days arm 2: placebo identical to levofloxacin drug daily for 30 days

Interventions: intervention 1: levofloxacin intervention 2: placebo
Intervention descriptions: intervention 1: 500 mg tablet, daily, 30 days intervention 2: no dose, tablet, daily, 30 days

Protocol document: